These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8949981)

  • 21. Angiogenesis research. Cancer drugs found to work in new way.
    Barinaga M
    Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
    [No Abstract]   [Full Text] [Related]  

  • 22. Angiogenesis in bladder cancer--prognostic marker and target for future therapy.
    Streeter EH; Harris AL
    Surg Oncol; 2002 Jun; 11(1-2):85-100. PubMed ID: 12031871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR.
    Egawa S; Tsutsumi M; Konishi Y; Kobari M; Matsuno S; Nagasaki K; Futami H; Yamaguchi K
    Gastroenterology; 1995 May; 108(5):1526-33. PubMed ID: 7537236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Opening to the age of regenerative medicine--the mechanism of angiogenesis].
    Murota S
    Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
    Bergers G; Javaherian K; Lo KM; Folkman J; Hanahan D
    Science; 1999 Apr; 284(5415):808-12. PubMed ID: 10221914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
    Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
    J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-angiogenesis: biology is the foundation for therapy.
    Gerber HP
    Drug Discov Today; 2003 Apr; 8(8):344-6. PubMed ID: 12681937
    [No Abstract]   [Full Text] [Related]  

  • 28. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer.
    Maniwa Y; Okada M; Ishii N; Kiyooka K
    Chest; 1998 Dec; 114(6):1668-75. PubMed ID: 9872204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis research yields new approaches to cancer treatment and prognosis.
    Larsen NS
    J Natl Cancer Inst; 1993 Oct; 85(20):1629-30. PubMed ID: 7692073
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
    Stoeltzing O; Liu W; Reinmuth N; Parikh A; Ahmad SA; Jung YD; Fan F; Ellis LM
    Ann Surg Oncol; 2003 Aug; 10(7):722-33. PubMed ID: 12900362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of angiogenic growth factors and their inhibitors.
    Ferrara N; Alitalo K
    Nat Med; 1999 Dec; 5(12):1359-64. PubMed ID: 10581076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor.
    Kanamori S; Nishimura Y; Okuno Y; Horii N; Saga T; Hiraoka M
    Int J Hyperthermia; 1999; 15(4):267-78. PubMed ID: 10458567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiangiogenic treatment of cancer].
    Mauriz JL; Linares P; González P; Culebras JM
    Cir Esp; 2005 Jul; 78(1):3-11. PubMed ID: 16420784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation, angiogenesis, and venous thromboembolism in cancer.
    Agorogiannis EI; Agorogiannis GI
    Lancet; 2002 Apr; 359(9315):1440. PubMed ID: 11978375
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenesis: towards a molecular tourniquet.
    Geisow MJ
    Trends Biotechnol; 1991 Mar; 9(3):78-9. PubMed ID: 1370030
    [No Abstract]   [Full Text] [Related]  

  • 40. Promises and pitfalls of anti-angiogenic therapy in clinical trials.
    McCarty MF; Liu W; Fan F; Parikh A; Reimuth N; Stoeltzing O; Ellis LM
    Trends Mol Med; 2003 Feb; 9(2):53-8. PubMed ID: 12615038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.